ArticleJournal of public health policy2014
Commentary: a targets framework: dismantling the invisibility trap for children with drug-resistant tuberculosis.
Article in Journal of public health policy, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 30 citations in OpenAlex.
- Tuberculosis incidence is high in HIV-infected African children but is reduced by co-trimoxazole and time on antiretroviral therapy.BMC medicine · 2016Trial
- Review
- Epidemiological characteristics of pulmonary tuberculosis among children in Shandong, China, 2005-2017.BMC infectious diseases · 2019Article
- Transmission of drug-resistant tuberculosis in HIV-endemic settings.The Lancet. Infectious diseases · 2019Review
- Multiparameter Responses to Tedizolid Monotherapy and Moxifloxacin Combination Therapy Models of Children With Intracellular Tuberculosis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2018Article
- Time to Drug-Resistant Tuberculosis Treatment in a Prospective South African Cohort.Global pediatric health · 2017Article
- A Combination Regimen Design Program Based on Pharmacodynamic Target Setting for Childhood Tuberculosis: Design Rules for the Playground.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2016Review
- Two methods for setting child-focused tuberculosis care targets.Public health action · 2016Article
- A Long-term Co-perfused Disseminated Tuberculosis-3D Liver Hollow Fiber Model for Both Drug Efficacy and Hepatotoxicity in Babies.EBioMedicine · 2016Article
- Global Burden of Childhood Tuberculosis.Pneumonia (Nathan Qld.) · 2016Article
- Childhood abdominal tuberculosis: Disease patterns, diagnosis, and drug resistance.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2015Review
- Programmatic management of children with drug-resistant tuberculosis: common sense and social justice.Public health action · 2015Article
- Map the gap: missing children with drug-resistant tuberculosis.Public health action · 2015Article
- The 'invisibility' of children with tuberculosis.Journal of public health policy · 2015Article
- A proposal to rethink how we track tuberculosis spread around the world.Journal of public health policy · 2014Article
- Multidrug-resistant tuberculosis infection and disease in children: a review of new and repurposed drugs.Therapeutic advances in infectious diseaseReview
Corrections and comments
- Commented on by
- Commented on by
Authors and funding
2 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tuberculosis (TB) is an airborne infectious disease that is both preventable and curable, yet it kills more than a million people every year. Children are highly vulnerable, but often invisible casualties. Drug-resistant forms of TB are on the rise globally, and children are as vulnerable as adults but less likely to be counted as cases of drug-resistant disease if they become sick. Four factors make children with drug-resistant TB 'invisible': first, the nature of the disease in children; second, deficiencies in existing diagnostic tools; third, overreliance on these tools; and fourth, our collective failure to deploy one effective tool for finding and treating children - contact investigation. We describe a nascent science-advocacy network - the Sentinel Project on Pediatric Drug-Resistant Tuberculosis - whose goal is to end child deaths from this disease. Provisional annual targets, focused on children exposed at home to multidrug-resistant TB, to be updated every year, constitute a framework to focus attention and collective actions at the community, national, and global levels. The targets in two age groups, under 5 and 5-14 years old, tell us the number of: (i) children who require complete evaluation for TB disease and infection; (ii) children who require treatment for TB disease; and (iii) children who would benefit from preventive therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.